1 metabolic changes through induction of Glucose transporter 1 (GLUT-1) (SLC2A1).
2, 3 We previously reported that mutant KRAS has marked effects on the constituents of CRC exosomes, including proteins and enzymes involved in metabolism and glycolysis. 4, 5 The present studies were designed to test whether mutant KRAS exosomes can alter the metabolic state cell-nonautonomously in recipient colonic epithelial cells.
We isolated exosomes purified from Daniel L. Dexter derived 1 (DLD-1) cells, which contain 1 wild-type (WT) and 1 mutant KRAS allele, and those from DLD-1 isogenic cell variants genetically engineered to express only the WT KRAS allele (DKs-8) or only the mutant KRAS allele (DKO-1). 6 Adding DKO-1 exosomes to DKs-8 cells significantly reduced glucose concentrations in the medium, suggesting increased cellular glucose uptake in these WT KRAS cells ( Figure 1A ). After 48-hour exposure to DKO-1 exosomes, a significantly higher percentage of recipient DKs-8 cells were in S and G2/M phases of the cell cycle (Supplementary Figure 1A and B) , and cell number was increased at 120 hours (Supplementary Figure 1C) . We next used the endogenous fluorescent characteristics of Nicotinamide adenine dinucleotide reduced (NADH) and Flavin adenine dinucleotide (FAD) to determine the relative balance between glycolysis and oxidative phosphorylation, as previously reported. [7] [8] [9] Addition of mutant KRAS exosomes selectively and significantly increased F-FSPG is a novel positron emission tomography tracer that follows the import of cystine by the glutamate/cysteine antiporter SLC7A11, which is overexpressed in CRC. 10 We found that Apc Min/þ mice injected with DKO-1 exosomes had a significant increase in 18 F-FSPG uptake in the tumor region ( Figure 1C and Supplementary Figure 3B and C), suggesting that mutant KRAS CRC exosomes can alter tumor cell metabolism in vivo.
Levels of GLUT-1 were increased in DKO-1 exosomes, as well as in cell lysates ( Figure 2A ). To test whether these mutant KRAS exosomes contained functional GLUT-1, we measured 18 Ffluorodeoxyglucose incorporation. After 1 hour, 18 F-fluorodeoxyglucose uptake was significantly higher in DKO-1 exosomes ( Figure 2B ). The purified exosomes showed the characteristic cup-shaped morphology and size reported for exosomes (40-100 nm) (Supplementary Figure 4A and B) . Further purification of exosomes on an iodixanol density gradient showed that GLUT-1 was present in the fractions that contain established exosomal markers (Supplementary Figure 4C) . Thus, mutant KRAS exosomes contain increased levels of functional GLUT-1.
Targeted disruptions of both alleles of GLUT1 in DLD-1 cells (GLUT-1 knockout [KO]) led to loss of detectable GLUT-1 protein (Supplementary Figure 4D ) and significantly reduced uptake of radiolabeled glucose in these exosomes ( Figure 2C ). None of the other glucose transporters tested (GLUT-2, GLUT-3, and GLUT-4) were detected in these exosomes (data not shown). We treated recipient DLD-1 GLUT-1 KO cells with exosomes isolated from DLD-1 parental or GLUT-1 KO cells for 43 hours and measured metabolite uptake and secretion using In summary, we show that mutant KRAS exosomes are able to confer a Warburg-like effect on recipient colonic epithelial cells in vitro and in vivo. Increased functional exosomal GLUT-1 contributes to metabolic changes in recipient cells. These preliminary observations should prompt further study of exosomes in tumor metabolism. Coffey designed experiments, analyzed data, wrote the paper, and supervised the work.
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Supplementary Materials and Methods
Cell Culture and Reagents DLD-1, DKs-8, DKO-1, 1 and DLD-1 GLUT-1 knockout cells were cultured as described previously. 2, 3 Propidium iodide was purchased from Invitrogen/ Molecular Probes (Carlsbad, CA) and Hoechst was purchased from Sigma (St. Louis, MO).
Exosome Isolation and Characterization
Exosomes were isolated from conditioned medium of DKs-8, DKO-1, DLD-1, and DLD-1 GLUT-1 KO cells as previously described. 2 The diameter of exosomes (mean diameter, 50 nm) was obtained by nanoparticle tracking analysis (NanoSight, Wiltshire, United Kingdom; N ¼ 4) as previously described. 4 Electron microscopic imaging of exosomes was performed as previously described. 4 Exosome pellets from DKO-1 cells were applied to the bottom of a discontinuous 5%-45% iodixanol (OptiPrep, SigmaAldrich) gradient and subjected to ultracentrifugation at 120,000 Â g for 16 hours at 4 C using a TH-641 swinging bucket rotor (k factor of 114; Thermo Scientific [Waltham, MA]). Fractions (1 mL) were collected from the top of the gradient. Each fraction was diluted in phosphate-buffered saline and subjected to ultracentrifugation at 120,000 Â g for 4 hours at 4 C using a SureSpin 630 (k factor of 219; Thermo Scientific) swinging bucket rotor.
Positron Emission Tomography Agent Synthesis

18
F-Fluorodeoxyglucose was obtained commercially from PETNET (Siemens Healthcare Diagnostics, Inc, Tarrytown, NY) with an average radiochemical purity of 98.5% and specific activity of greater than 1000 Ci/mmol. 18 F-FSPG was prepared as previously described. 5 
F-Fluorodeoxyglucose Incorporation
A total of 50 mCi of 18 Ffluorodeoxyglucose was added to 50 mL of DKs-8, DKO-1 DLD-1, or DLD-1 GLUT-1 KO cell-derived exosomes (1 mg/mL) in phosphate-buffered saline-HEPES, pH 7.2, and these samples were incubated at 37ºC for 1 hour. Ethylenimine (0.05%; Sigma) then was added and the solution was placed on an Isolute Phase Separator (Biotage, Charlotte, NC) fitted with a GF/B filter (Brandel, Inc, Gaithersburg, MD). Filters were washed, removed, and radioactivity was measured. Analysis was performed on at least 3 independent preparations of exosomes.
Immunoblot Analysis
Immunoblotting of cell lysates and exosomes was performed as previously described.
3,4 Primary antibodies were epidermal growth factor receptor (1:1000; Millipore, Burlington, MA), syntenin-1 (1:5000; Abcam, Cambridge, MA), CD81 (1:1000; R&D Systems, Minneapolis, MN), GLUT-1 (1:1000, mouse; Abcam), GLUT-3 (1:1000; Abcam), and Alix (1:10,000; Cell Signaling, Danvers, MA). Secondary antibodies were rabbit IgG, horseradish peroxidase-linked antibody (1:1000; Sigma); mouse IgG, horseradish peroxidase-linked (1:5000; Jackson Immunoresearch, West Grove, PA); and IR-800 antibody (1:15,000; LI-COR, Lincoln, NE). Immunoblots were imaged by fluorescence detection using an Odyssey Fc Imaging System (LI-COR).
Measurement of Cellular Glucose Consumption
Before plating, 5 Â 10 5 DKs-8 cells were incubated with 50 mg exosomes or mock treated for 1 hour at 37 C. Cells were plated in 48-well dishes at 24,000 cells per well (in triplicate). Dulbecco's modified Eagle medium containing 5 mmol/L glucose (Sigma) and 3% fetal calf serum was added to each well. At the indicated times, medium was removed and stored at -80 C, and cell number was counted by measuring the fluorescent intensity of SYBR green (Invitrogen) staining. Glucose concentration in the medium was measured (normalized to cells per well, N ¼ 3 in triplicate) using the Glucose Colorimetric Assay Kit (Cayman Chemical, Ann Arbor, MI), according to the manufacturer's directions.
Analysis of Cell-Cycle Progression
Before plating, 1.0 Â 10 6 DKs-8 cells were incubated with 100 mg exosomes or mock treated for 1 hour at 37 C, plated in 10-cm tissue culture dishes and Dulbecco's modified Eagle medium containing 5 mmol/L glucose, and 3% fetal calf serum was added and incubated for the indicated times. A total of 2 mg/mL of Hoechst 33342 (Sigma) was added to each plate 1 hour before harvest. Fifty thousand cells were washed and resuspended in 500 mL of phosphatebuffered saline supplemented with 3% fetal calf serum and the cell cycle was analyzed by flow cytometry. Samples were analyzed on a BD LSR II (Franklin Lakes, NJ) equipped with a solid-state UV laser. Doublet discrimination was used with appropriate pulse geometries 6 (n ¼ 3 in triplicate).
Isolation and Culturing of Mouse Colonic Cells
This procedure was performed as previously described.
7,8
Optical Metabolic Imaging
After trypsinization and washing, DKs-8 or mouse colonic epithelial cells were centrifuged and resuspended at 1 Â 10 6 cells/mL in highglucose Dulbecco's modified Eagle medium containing 3% fetal calf serum. Medium was supplemented with 100 mg/mL DKs-8 or DKO-1 cell-derived exosomes or 100 mL phosphate-buffered saline. Cells were incubated at 37 C for 60 minutes. Twenty thousand cells per well were plated in 24-well dishes and incubated for 48 hours at 37 C, and then optical metabolic imaging was performed. For colonoid experiments, cells were cultured in Matrigel (Corning, Tewksbury, MA) using minigut medium and then placed in 24-well agar-coated dishes. A total of 100 mg of DKs-8 or DKO-1 exosomes or 100-mL phosphate-buffered saline were added to the 400 mL of minigut medium in each well and orbitally rocked at 37 C for 1 hour followed by a 48-or 96-hour incubation at 37 C and then imaged.
Multiphoton optical metabolic imagining microscopy of NADH and FAD was performed on a custom-built, multiphoton fluorescence microscope (Bruker, Bremen, Germany), as previously described. [9] [10] [11] Individual cells within the image were segmented using a customized routine in CellProfiler (Carpenter Lab at the Broad Institute of Harvard and MIT, Cambridge, MA) 12 and the mean redox ratio for each cell was computed as the ratio of NADH fluorescence intensity divided by FAD fluorescence intensity.
In Vivo Imaging
All procedures were approved by and performed in accordance with Vanderbilt University Animal Care and Use Committee guidelines. Apc Min/þ or WT (non-tumor-bearing) mice were screened for colonic tumors by colonoscopy. Before imaging, mice were injected for 4 consecutive days with 300 mg of DKs-8 or DKO-1 exosomes in 500 mL of phosphate-buffered saline. Mock-treated mice were injected with 500 mL of phosphate-buffered saline. For 18 F-FSPG positron emission tomography imaging, mice were imaged with microPET Focus 220 (Siemens Preclinical Solutions, Knoxville, TN) and NanoSPECT/CT (Bioscan, Washington, DC) 2 hours after the final exosome or mock injection as previously described. 13, 14 Regions-ofinterest determination was guided by anatomic magnetic resonance images (Varian, Inc, Palo Alto, CA). Similarsized regions-of-interest were drawn around the tumors and hind limb muscles. The 18 FSPG signal was expressed as the tumor-to-muscle uptake ratio. Comparisons between groups were performed using a 1-way analysis of variance followed by a Tukey test. For magnetic resonance images, multislice scout images were collected in all 3 imaging planes (axial, sagittal, and coronal) using a gradient echo sequence with a repetition time of 75 ms, echo time of 5 ms, slice thickness of 2 mm, flip angle of 35 , and an average of 4 acquisitions. Additional parameters included field of view of 50 mm Â 50 mm and data matrix of 128 Â 128 pixels.
Tissue Preparation
Tissue were processed as previously described, 15 except after positron emission tomography imaging when representative colonic tumors were dissected, they were then placed in Dulbecco's modified Eagle medium containing 10% fetal calf serum, and subjected to optical metabolic imaging.
Proton Magnetic Resonance ( 1 H-MRS) of Cell Culture Media
Before plating, 5 million DLD-1 GLUT-1 KO cells were incubated with 500 mg exosomes isolated from parental DLD-1 cells or DLD-1 GLUT-1 KO cells, or mock treated for 1 hour with rotation at 37 C. Cells were plated in 10-cm dishes with 5 million cells per dish (in triplicate) with Dulbecco's modified Eagle medium containing 10% fetal calf serum depleted of bovine exosomes as previously described. 16 After 43 hours, fresh cell culture medium and cellconditioned medium were collected for metabolite measurements. A total of 50 mL D 2 O (Sigma-Aldrich) and 50 mL of 0.75% sodium 3-trimethylsilyl-2,2,3,3-tetradeuteropropionate in D 2 O (SigmaAldrich) were added to 500 mL media in 5-mm NMR tubes (Wilmad-LabGlass, Kingsport, TN) for chemical shift calibration and quantification. 1 H-MRS spectra were acquired on an Avance III 600 MHz spectrometer equipped with a Triple Resonance CryoProbe (TCI) (Bruker) at 298 K with 7500-Hz spectral width, 32,768 time domain points, 32 scans, and a relaxation delay of 2.7 seconds. The water resonance was suppressed by a gated irradiation centered on the water frequency. The spectra were phased, manually baseline corrected, and referenced to sodium 3-trimethylsilyl-2,2,3,3-tetradeuteropropionate using the Bruker TopSpin-3.5 software package. Spectral assignments were based on literature values. 17 
Statistical Methods
All analyses were conducted within the framework of mixed models analysis of variance. Variation between experiments conducted on separate days was modeled as a random effect. Data transformations were evaluated to meet normality assumptions. Repeated measures in sampling (eg, multiple fields analyzed within mice from the in vivo study) were modeled using a compound symmetry covariance structure. Goodness-of-fit was evaluated via analysis of model residuals. Comparisons between groups were performed as described earlier.
Statistical analysis was conducted using GraphPad Prism version 6 for Mac OS X (Cupertino, CA) (GraphPad Software, Inc, San Diego, CA).
